peroxynitrous acid has been researched along with Brain Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, SF; Barrera, D; Galván-Arzate, S; Pedraza-Chaverrí, J; Pérez-de La Cruz, V; Rembao, D; Salinas-Lara, C; Santamaría, A; Santiago-López, D; Vázquez-Román, B | 1 |
| Hader, W; Yang, C; Zhang, X | 1 |
2 other study(ies) available for peroxynitrous acid and Brain Diseases
| Article | Year |
|---|---|
Peroxynitrite decomposition catalyst, iron metalloporphyrin, reduces quinolinate-induced neurotoxicity in rats.
Topics: Animals; Antioxidants; Brain Diseases; Corpus Striatum; Iron; Male; Metalloporphyrins; Neurotoxins; Nitrogen; Oxidative Stress; Peroxynitrous Acid; Quinolinic Acid; Rats; Rats, Wistar; Tyrosine | 2004 |
Therapeutic action of cannabinoid on axonal injury induced by peroxynitrite.
Topics: Adrenalectomy; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Axons; Brain Diseases; Cannabinoids; Corpus Callosum; Corticosterone; Disease Models, Animal; Dronabinol; Drug Therapy, Combination; Enzyme Inhibitors; Immunohistochemistry; Male; Molsidomine; Morpholines; Peroxynitrous Acid; Pyrazoles; Rats; Rats, Wistar | 2006 |